-
-
Call more information
660-596-2224 -
Only a fraction of Medicare patients who have opioid use disorder receive opioid agonist therapy (OAT) with buprenorphine-naloxone (multiple brands), say US researchers, who found that nonspecialist physicians are the least likely to prescribe the drug. The Medicare population of 55 million patients has one of the largest and fastest growing rates of opioid use […]
Read MoreAuthors: Shiyang Li et al BMC Anesthesiol. 2016;16(24) Background: Propofol and fentanyl are the most widely administered anesthesia maintaining drugs during colonoscopy. In this study, we determined the median effective concentration (EC50) of propofol required for colonoscopy in elderly patients, and the purpose of this study was to describe the pharmacodynamic interaction between fentanyl and propofol when […]
Read MoreCommon surgical procedures were associated with increased risk for chronic opioid use in the first year after surgery by opioid-naïve patients and some patients were particularly vulnerable, according to a study published online by JAMA Internal Medicine. Opioid sales have increased dramatically over the last decade, especially to relieve noncancer pain, resulting in increased opioid-related […]
Read MoreWomen who undergo axillillary node surgery for breast cancer are much more likely to develop chronic pain, according to a study published in the Canadian Medical Association Journal (CMAJ). “Ten-year survival rates for breast cancer patients are now around 83%, but up to 60% of women who undergo surgery as part of cancer treatment, may develop […]
Read MoreResearchers have uncovered a more effective way of treating fibromyalgia by combining with duloxetine. The combination can safely improve outcomes in patients with fibromyalgia, including relief from pain, physical function, and overall quality of life. “Previous evidence supports added benefits with some drug combinations in fibromyalgia,” said Ian Gilron, MD, Queen’s University, Kingston, Ontario. “We […]
Read More